Education
About Us
Working with TipRanks
Follow Us
Envoy Medical (COCH)
NASDAQ:COCH
COCH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.06 - $3.99
Previous CloseN/A
Volume61.49K
Average Volume (3M)499.66K
Market Cap
$25.18M
Enterprise Value$53.91M
Total Cash (Recent Filing)$5.29M
Total Debt (Recent Filing)$901.00K
Price to Earnings (P/E)―
Beta0.35
Next Earnings
Nov 24, 2025EPS Estimate
-0.32Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.32
Shares Outstanding21,520,391
10 Day Avg. Volume1,461,545
30 Day Avg. Volume499,657
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap2.14
Enterprise Value/Revenue242.84
Enterprise Value/Gross Profit-92.63
Enterprise Value/Ebitda-2.80
Forecast
1Y Price Target
$5.50Price Target Upside354.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Bulls Say, Bears Say
Bulls Say
Market OpportunityThe company believes there is a significant market opportunity, with an estimated 25,000 to 30,000 adults in the U.S. getting cochlear implants annually by 2026, representing a market opportunity exceeding $750 million.
Product DevelopmentEnvoy has developed the Acclaim CI, a fully implanted cochlear implant that does not require any external component to be worn on the ear.
Regulatory ApprovalThe Acclaim CI received approval for its IDE application with the FDA to begin clinical testing and has already started trials with participants.
Bears Say
Development RisksEnvoy Medical’s devices still have long development and/or commercialization roads ahead, with high risks of clinical trials or commercial failures.
Financial PerformanceRevenue was ~$0 million, compared to estimates of $0.1 million, leading to a net loss of $9.1 million or EPS of $(0.46).
Profitability ConcernsConcerns are outweighed by growth prospects and valuation, with a billion dollars market potential presenting high rewards for the risks.
Envoy Medical News
COCH FAQ
What was Envoy Medical’s price range in the past 12 months?
Envoy Medical lowest stock price was $1.06 and its highest was $3.99 in the past 12 months.
What is Envoy Medical’s market cap?
Envoy Medical’s market cap is $25.18M.
When is Envoy Medical’s upcoming earnings report date?
Envoy Medical’s upcoming earnings report date is Nov 24, 2025 which is in 86 days.
How were Envoy Medical’s earnings last quarter?
Envoy Medical released its earnings results on Jul 31, 2025. The company reported -$0.32 earnings per share for the quarter, missing the consensus estimate of -$0.302 by -$0.018.
Is Envoy Medical overvalued?
According to Wall Street analysts Envoy Medical’s price is currently Undervalued.
Does Envoy Medical pay dividends?
Envoy Medical does not currently pay dividends.
What is Envoy Medical’s EPS estimate?
Envoy Medical’s EPS estimate is -0.32.
How many shares outstanding does Envoy Medical have?
Envoy Medical has 21,520,391 shares outstanding.
What happened to Envoy Medical’s price movement after its last earnings report?
Envoy Medical reported an EPS of -$0.32 in its last earnings report, missing expectations of -$0.302. Following the earnings report the stock price went down -6.41%.
Which hedge fund is a major shareholder of Envoy Medical?
Currently, no hedge funds are holding shares in COCH
Envoy Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.50 (354.55% Upside)
$5.50 (354.55% Upside)
Hedge Fund Trend
Decreased
By 297.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $18.3K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-59.53%
12-Months-Change
Fundamentals
Return on Equity
1697.39%
Trailing 12-Months
Asset Growth
46.95%
Trailing 12-Months
Company Description
Envoy Medical
Envoy Medical (COCH) is a medical device company specializing in developing innovative hearing solutions. The company operates within the healthcare sector, focusing on designing and manufacturing implantable hearing devices. Envoy Medical's core product is the Esteem Hearing Implant, a fully implantable active middle ear device designed to improve hearing for individuals with sensorineural hearing loss.
COCH Stock 12 Month Forecast
Average Price Target
$5.50
▲(354.55% Upside)
Technical Analysis
EDAP TMS
―
Modular Medical
―
NeuroOne Medical Technologies
―
Vivos Therapeutics
―
Adagio Medical Holdings
―
Ownership Overview
49.96% Insiders
2.19% Mutual Funds
0.77% Other Institutional Investors
45.15% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---